Halcinonide is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, and is distributed as a cream and ointment. Halcinonide is marketed under the brand name Halog® by Ranbaxy Laboratories Inc. Research suggests that clobetasol propionate demonstrates superior pharmacologic efficacy in the treatment of psoriasis when compared to halcinonide.
Halcinonide is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, and is distributed as a cream and ointment. Halcinonide is marketed under the brand name Halog® by Ranbaxy Laboratories Inc. Research suggests that clobetasol propionate demonstrates superior pharmacologic efficacy in the treatment of psoriasis when compared to halcinonide.
Indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found for this drug
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
---|---|---|---|---|---|
TOPICAL | 1 mg in 1 g | 2019/07/29 | 10631-096 | ||
TOPICAL | 1 mg in 1 g | 2024/01/09 | 71428-011 | ||
TOPICAL | 1 mg in 1 mL | 2021/05/18 | 10631-095 | ||
TOPICAL | 1 mg in 1 g | 2019/08/30 | 0378-8056 | ||
TOPICAL | 1 mg in 1 g | 2019/01/07 | 10631-094 | ||
TOPICAL | 1 mg in 1 g | 2021/05/27 | 57664-698 |
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
---|
No EMA products found for this drug
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
---|
No HSA products found for this drug
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
---|---|---|---|---|---|---|---|---|---|
国药准字H21022479 | 软膏剂 | N/A | 10g:10mg | Chemical Drug | Approved | 2020/07/23 | Domestic | ||
国药准字H13022113 | 软膏剂 | N/A | 10g:10mg | Chemical Drug | Approved | 2020/09/20 | Domestic | ||
国药准字H12020696 | 软膏剂 | N/A | 10g:10mg | Chemical Drug | Approved | 2019/12/04 | Domestic | ||
国药准字H21021578 | 软膏剂 | N/A | 0.1% | Chemical Drug | Approved | 2020/07/29 | Domestic | ||
国药准字H42021315 | 软膏剂 | N/A | 10g:10mg | Chemical Drug | Approved | 2020/06/10 | Domestic | ||
国药准字H41023690 | 软膏剂 | N/A | 10g:10mg | Chemical Drug | Approved | 2020/06/05 | Domestic | ||
国药准字H41021872 | 软膏剂 | N/A | 10g:10mg | Chemical Drug | Approved | 2020/05/06 | Domestic | ||
国药准字H32023721 | 软膏剂 | N/A | 10g:10mg | Chemical Drug | Approved | 2020/07/24 | Domestic | ||
国药准字H14021167 | 软膏剂 | N/A | 10g:10mg | Chemical Drug | Approved | 2020/07/28 | Domestic | ||
国药准字H20065742 | N/A | N/A | 10g:10mg | Chemical Drug | Approved | 2006/06/18 | Domestic |
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
---|
No PPB products found for this drug
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
---|
No TGA products found for this drug